Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |